Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... according to study published online November 10 in the Journal of the National Cancer Institute.Erythropoiesis-stimulating agents (i.e., erythropoietin and ... efforts at monitoring use and long-term toxicity of expensive oncology drugs should be put in place to ensure that for any drug the benefits outweigh the risks in ...
2009 NOV 29 ... of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and ...
2009 NOV 29 ... its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares ... material in this process. This finding may be useful for developing new, specific AIDS drugs.Like all retroviruses, the AIDS virus (HIV) integrates its DNA into the ...
Subject: Helmholtz Association of German Research Centres
2009 NOV 27 ... that could someday be used to treat a variety of diseases, especially multiple types of cancer."There is a pressing need for drugs that target transcription factors, both ...
2009 NOV 26 ... and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other ...
2009 NOV 23 ... bile acid reabsorption. In the colon, secondary bile acids increase the risk of cancer," scientists in the United States report. "Therefore, drugs that inhibit ...
2009 NOV 23 ... structure of the PKA catalytic subunit," wrote J. Seidler and colleagues, German Cancer Research Center. The researchers concluded: "The results add new ... Chromatography, Chymotrypsin, Diagnosis, Diagnostics, Dietary Supplement, Digestion, Drugs, Endoproteinase, Enzymes, Kinase, Micronutrient, Oncology, Pharmaceuticals, Therapy, ...
2009 NOV 23 ... New research, 'The economic consequences of breast cancer adjuvant hormonal treatments,' is the subject of a report. "Adjuvant hormone therapy ... Aromatase, Breast Cancer, Breast Carcinoma, Clinical Oncology, Clinical Trial Research, Drugs, Enzymes, Hormones, Internal Medicine, Oncology, Surgery, Tamoxifen, Therapy, Treatment, ...
2009 NOV 23 ... investigate the association of IFN-gamma T/A gene polymorphism with the risk of cervical cancer. Case-control study. Uttar Pradesh State in India. Sample Two hundred cases with ... Country:India, Cervical Cancer, Cervical Carcinoma, Clinical Trial Research, Drugs, Gynecology, Immunology, Interferon, Interferon Alfa-2b, Interferon Gamma, Intron, ...
2009 NOV 23 ... nonclinical studies of voreloxin at the upcoming AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference, which is being held in Boston, MA from November 15-19, 2009. ... Inc., Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Cytarabine, Drugs This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 23 ... alongside increases in lifestyle related problems faced by the developed world, such as cancer, cardiovascular disease and diabetes. India has more US FDA approved ... pharmaceutical industry tends to focus on the manufacture of cheap generics and copycat drugs and counterfeiting remains a problem. Imports of pharmaceuticals, particularly that of ...
2009 NOV 23 ... Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 ... Trial Research, Clinical Trials, Drug Development, Drug Resistance, Drug Therapy, Drugs, Enzymes, Lyase, Oncology, Pharmaceuticals, Pre-Trials Research, Prostate Cancer, ...
2009 NOV 23 ... In the quarter, the Oncologic Drugs Advisory Committee (ODAC), which is the cancer drug advisory panel of the U.S. Food and Drug Administration (FDA), voted in favor of ...
2009 NOV 29 ... women worldwide, killing more than 8.6 million, more than the total number who die from cancer, tuberculosis, HIV/AIDS and malaria combined.However, the risk for women is ... director of the EHN, regrets that, as a result, "safety and efficacy of several drugs have been evaluated predominantly in male populations."Professor ...
2009 NOV 23 ... BPA effects than other disease endpoints that are more difficult to study, such as cancer or metabolic diseases. For this study, researchers compared 230 workers ... Research and National Population & Family Planning Key Laboratory of Contraceptive Drugs and Devices; and H. Checkoway, Ph.D. of Department of Environmental Health, University ...
2009 NOV 23 ... company engaged in the development and commercialization of a diverse portfolio of cancer drugs. The Company is currently focused on three clinical programs. Palifosfamide ...
2009 NOV 23 ... seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, reported its financial results for the quarter ended ...
